Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Jiu-Chang Zhong"'
Autor:
Jing Li, Yang Shen, Kaixin Yan, Siyuan Wang, Jie Jiao, Hongjie Chi, Jiu-chang Zhong, Ying Dong, Pan Wang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background The prevalence of chronic kidney disease (CKD) is on the rise, posing a significant public health challenge. Although gut microbiome dysbiosis has been implicated in the impairment of kidney functions, the existence of pathologica
Externí odkaz:
https://doaj.org/article/649cc9f86e964b308ecd5b564aa83f06
Autor:
Jing Li, Si‐Yuan Wang, Kai‐Xin Yan, Pan Wang, Jie Jiao, Yi‐Dan Wang, Mu‐Lei Chen, Ying Dong, Jiu‐Chang Zhong
Publikováno v:
iMeta, Vol 3, Iss 4, Pp n/a-n/a (2024)
Abstract Dysbiosis of the gut microbiota has been implicated in hypertension, and drug–host–microbiome interactions have drawn considerable attention. However, the influence of angiotensin receptor blocker (ARB)‐shaped gut microbiota on the hos
Externí odkaz:
https://doaj.org/article/d63331118e0d432eae2266815cf71cf8
Autor:
Yi-Xing Yang, Huai-Peng Zhang, Chuang Li, Yuan Fu, Kui-Zheng He, Xin-Ming Liu, Hong-Jiang Wang, Kun Xia, Li Xu, Jiu-Chang Zhong, Mu-Lei Chen, Le-Feng Wang
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-11 (2023)
Abstract Background Treatment for cancer patients presenting with acute myocardial infarction (AMI) remains challenging. The objective of the study was to investigate the safety and efficiency of drug eluting balloon (DEB) versus drug eluting stent (
Externí odkaz:
https://doaj.org/article/9a08e4a8fcb34702b9905eeb64f8b9de
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Atrial fibrillation (AF) is a common arrhythmia in patients with hypertension. ELABELA, which has cardioprotective effects, is decreased in the plasma of patients with hypertension and might be associated with AF in the hypertensi
Externí odkaz:
https://doaj.org/article/f8db3a4fa9404debb4f4e464266efa1c
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 22, Iss 1, Pp 127-135 (2021)
Cardiovascular diseases (CVD), especially acute myocardial infarction, are the leading cause of death, morbidity and disability across the world, affecting millions of people each year. Atherosclerosis (AS) is the major cause of CVD, and is a chronic
Externí odkaz:
https://doaj.org/article/bd8abc94ba124e1799d39d516a74581d
Autor:
Yu Liu, Le-Feng Wang, Xin-Chun Yang, Chang-Lin Lu, Kui-Bao Li, Mu-Lei Chen, Na Li, Hong-Shi Wang, Jiu-Chang Zhong, Li Xu, Zhu-Hua Ni, Wei-Ming Li, Kun Xia, Da-Peng Zhang, Hao Sun, Zong-Sheng Guo, Yong-Hui Chi, Ji-Fang He, Zhi-Yong Zhang, Feng Jiang, Hong-Jiang Wang
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Objectives To investigate the long-term outcome of patients with acute ST-segment elevation myocardial infarction (STEMI) and a chronic total occlusion (CTO) in a non-infarct-related artery (IRA) and the risk factors for mortality. Methods T
Externí odkaz:
https://doaj.org/article/4ea4c434d6e542b79cb0556a3bc94017
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
Cardiovascular diseases (CVDs) are still the main cause of morbidity and mortality worldwide and include a group of disorders varying from vasculature, myocardium, arrhythmias and cardiac development. MicroRNAs (miRs) are endogenous non-coding RNAs w
Externí odkaz:
https://doaj.org/article/36546cc175814484973019a243ae1abb
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Elabela, a novel cardiac developmental peptide, has been shown to improve heart dysfunction. However, the roles and correlation of Elabela in predicting adverse cardiac events in hypertensive patients with heart failure (HF) remain largel
Externí odkaz:
https://doaj.org/article/ea3b1f98c05448eeaaa168c64cad8adf
Publikováno v:
International Journal of Hypertension, Vol 2015 (2015)
The renin-angiotensin aldosterone system (RAAS) plays a pivotal role in the development of hypertension. Angiotensin converting enzyme 2 (ACE2), which primarily metabolises angiotensin (Ang) II to generate the beneficial heptapeptide Ang-(1-7), serve
Externí odkaz:
https://doaj.org/article/9abdb3c5b7364d43b3316e184e41d1f5
Autor:
Hai-Yan Jin, Bei Song, Gavin Y Oudit, Sandra T Davidge, Hui-Min Yu, Yan-Yan Jiang, Ping-Jin Gao, Ding-Liang Zhu, Guang Ning, Zamaneh Kassiri, Josef M Penninger, Jiu-Chang Zhong
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38502 (2012)
Inflammation and oxidative stress play a crucial role in angiotensin (Ang) II-mediated vascular injury. Angiotensin-converting enzyme 2 (ACE2) has recently been identified as a specific Ang II-degrading enzyme but its role in vascular biology remains
Externí odkaz:
https://doaj.org/article/e8d3b4f122cc49d1b32314a76abb9123